Kinnari Patel, Chief Operating Officer at ROCKET PHARMACEUTICALS, INC. (RCKT), bought 1,000 shares at $9.50 ($10K) on 2020-03-18, disclosed to the SEC on 2020-03-19.
Open-market purchase of $10k RCKT by Chief Operating Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| RCKT | BUY | 2025-04-10 | $198K | — | Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |